Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Forty Seven Inc (FTSV)

Forty Seven Inc (FTSV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,599,379
  • Shares Outstanding, K 48,156
  • Annual Sales, $ 15,680 K
  • Annual Income, $ -87,620 K
  • 60-Month Beta 0.40
  • Price/Sales 293.21
  • Price/Cash Flow N/A
  • Price/Book 12.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.67
  • Number of Estimates 4
  • High Estimate -0.61
  • Low Estimate -0.71
  • Prior Year -0.74
  • Growth Rate Est. (year over year) +9.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.00 +8.53%
on 03/18/20
95.51 -0.01%
on 04/06/20
+1.16 (+1.23%)
since 03/06/20
3-Month
32.29 +195.79%
on 01/13/20
95.51 -0.01%
on 04/06/20
+57.40 (+150.62%)
since 01/06/20
52-Week
5.53 +1,627.12%
on 10/23/19
95.51 -0.01%
on 04/06/20
+78.08 (+447.96%)
since 04/05/19

Most Recent Stories

More News
Gilead Completes Acquisition of Forty Seven, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Toro Merger Sub, Inc., a wholly owned subsidiary of Gilead ("Purchaser"), to acquire Forty...

GILD : 74.67 (-3.94%)
FTSV : 95.51 (+0.05%)
Demand for Essential Goods Rises Amid Coronavirus: 3 Winners

Despite the lagging markets, companies that offer pharmaceuticals and FMCG products have witnessed a surge in recent weeks, largely driven by strong demand for their goods.

GO : 36.74 (-1.34%)
TRIL : 3.94 (-1.50%)
FTSV : 95.51 (+0.05%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds MEET, CBB, DLPH, and FTSV Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (NASDAQ:MEET),(NYSE:CBB),(NYSE:DLPH),(NASDAQ:FTSV), EQNX::TICKER_END

MEET : 5.96 (-0.17%)
CBB : 14.57 (-1.09%)
DLPH : 7.62 (-5.22%)
FTSV : 95.51 (+0.05%)
FTSV, MEET, MINI, and NTGN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

FTSV : 95.51 (+0.05%)
MEET : 5.96 (-0.17%)
MINI : 23.80 (+3.70%)
NTGN : 2.32 (-9.73%)
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - FTSV, MINI, MEET, WLTW

Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional...

FTSV : 95.51 (+0.05%)
MINI : 23.80 (+3.70%)
MEET : 5.96 (-0.17%)
WLTW : 178.69 (+1.90%)
Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

IBB : 109.54 (-1.94%)
CNCR : 19.66 (-2.82%)
BBH : 131.68 (-1.40%)
ARKG : 31.48 (-0.98%)
AYTU : 1.5400 (-1.91%)
FTSV : 95.51 (+0.05%)
VIR : 32.09 (-12.56%)
IDNA : 26.88 (-2.08%)
CODX : 9.09 (-11.83%)
CNTG : 20.40 (+3.34%)
Lifshitz Law Firm, P.C. Announces Investigation of Forty Seven, Inc., Hexcel Corporation, Legg Mason, Inc., and Mobile Mini, Inc.

EQNX::TICKER_START (NASDAQ:FTSV),(NYSE:HXL),(NYSE:LM),(NASDAQ:MINI), EQNX::TICKER_END

FTSV : 95.51 (+0.05%)
HXL : 34.01 (+8.69%)
LM : 48.99 (+0.64%)
MINI : 23.80 (+3.70%)
Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights

-- Presented Updated Data for Magrolimab Showing Robust, Durable Activity in MDS and AML --

FTSV : 95.51 (+0.05%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds DLPH, FTSV, SMRT, and FHN Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (NYSE:DLPH),(NASDAQ:FTSV),(NASDAQ:SMRT),(NYSE:FHN), EQNX::TICKER_END

DLPH : 7.62 (-5.22%)
FTSV : 95.51 (+0.05%)
SMRT : 0.3546 (-1.25%)
FHN : 8.09 (+3.06%)
FORTY SEVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FTSV and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Forty Seven, Inc. (NASDAQ: FTSV) breached their fiduciary...

GILD : 74.67 (-3.94%)
FTSV : 95.51 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade FTSV with:

Business Summary

Forty Seven, Inc. is a clinical-stage immuno-oncology company. It focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer. The company's product candidate consists of 5F9, is an IgG4 monoclonal antibody against CD47 which is designed to interfere with recognition...

See More

Key Turning Points

2nd Resistance Point 95.55
1st Resistance Point 95.53
Last Price 95.51
1st Support Level 95.47
2nd Support Level 95.44

See More

52-Week High 95.51
Last Price 95.51
Fibonacci 61.8% 61.14
Fibonacci 50% 50.52
Fibonacci 38.2% 39.90
52-Week Low 5.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar